Drugmakers are down with AI, experts agree. They're just not sure what to use it for

Pharma’s plenty enthusiastic when it comes to artificial intelligence. The thing is, companies aren’t exactly sure yet how they should be using it.

That was the prevailing opinion at a recent roundtable in the AI hotbed of Montreal, Canada, where the Government of Quebec—which recently rolled out an ambitious plan to become a top-5 sector hub in North America by 2027—assembled pros from across the field to discuss the state of AI today.